Taurine bromamine: A new therapeutic option in inflammatory skin diseases

Polskie Archiwum Medycyny Wewnetrznej

Volumn 119, Issue 10, 2009, Pages 673-676

  Marcinkiewicz, Janusz ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Acne vulgaris; Inflammation; Myeloperoxidase; Propionibacterium acnes; Taurine bromamine

Indexed keywords

CLINDAMYCIN; TAURINE BROMAMINE; TAURINE DERIVATIVE; UNCLASSIFIED DRUG;

ACNE VULGARIS; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; NONHUMAN; PROPIONIBACTERIUM ACNES;

EID: 72249105324     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.807     Document Type: Article

References (31)

1. Thomas EL, Bozeman PM, Jefferson MM, et al. Oxidation of bromide by the human leukocyte enzymes myeloperoxidase and eosinophil peroxidase. J Biol Chem. 1995; 270: 2906-2913.
2. Henderson JP, Byun J, Williams MV, et al. Production of brominating intermediates by myeloperoxidase. J Biol Chem. 2001; 11: 7867-7875.
3. Nagl M, Hess MW, Pfaller K, et al. Bactericidal activity of micromolar N-chlorotaurine: evidence for its antimicrobial function in the human defense system. Antimicrob. Agents Chemother. 2000; 44: 2507-2513.
4. Yazdanbakhsh M, Eckmann CM, Roos D. Killing of schistosomula by taurine chloramine and taurine bromamine. Am J Trop Med Hyg. 1987; 37: 106-110. (Pubitemid 17155350)
5. Klebanoff SJ. Myeloperoxidase: friend and foe. J Leukoc Biol. 2005; 77: 598425.
6. Leam DB, Fried VA,Thomas EL. Taurine and hypotaurine content of human leukocytes. J Leukoc Biol. 1990; 48: 174-182.
7. Weiss SJ, Klein R, Slivka A, et al. Chlorination of taurine by human neutrophils: evidence for hypochlorus acid generation. J Clin Invest. 1982; 70: 598-603. (Pubitemid 12054584)
8. Marcinkiewicz J. Neutrophil chloramines - missing link between innate and acquired immunity. Immunol Today. 1997; 18: 677-680. (Pubitemid 28010969)
9. Marcinkiewicz J, Chain B, Nowak B, et al. Antimicrobial and cytotoxic activity of hypochlorous acid: interactions with taurine and nitrite. Inflamm Res. 2000; 49: 280-289. (Pubitemid 30451611)
10. Park E, Schuller-Levis G, Jia JH, et al. Preactivation exposure of RAW 264.7 cells to taurine chloramines attenuates subsequent production of nitric oxide and expression of iNOS mRNA. J Leukoc Biol. 1997; 61: 161-166. (Pubitemid 27081377)
11. Marcinkiewicz J, Grabowska A, Bereta J, et al. Taurine chloramine down-regulates the generation of murine neutrophil inflammatory mediators. Immunopharmacology. 1998; 40: 27-38. (Pubitemid 28434951)
12. Marcinkiewicz J, Mak M, Bobek M, et al. Is there a role of taurine bromamine in inflammation? Interactive effects with nitrate and hydrogen peroxide. Inflamm Res. 2005; 54: 42-49. (Pubitemid 40385340)
13. Olszanecki R, Marcinkiewicz J. Taurine chloramines and taurine bromamine induce heme-oxygenase-1 in resting and LPS-stimulated J774.2 macrophages. Amino Acids. 2004; 27: 29-35. (Pubitemid 39178946)
14. Nagl M, Nguyen VA, Gottardi W, et al. Tolerability and efficacy of N-chlorotaurine in comparison with chloramine T for treatment of chronic leg ulcers with a purulent coating: a randomized phase II study. Br J Dermatol. 2003; 149: 590-597. (Pubitemid 37281593)
15. Marcinkiewicz J, Biedroń R, Bialecka A, et al. Susceptibility of Propionibacterium acnes and Staphylococcus epidermidis to killing by MPO- halide system products. Implication for taurine bromamine as a new candidate for topical therapy in treating acne vulgaris. Arch Immunol Ther Exp. 2006; 54: 61-68
16. Tokunaga S, Kanayama A, Miyamoto Y. Modification of IkBα by taurine bromamine inhibits tumor necrosis factor α-induced NF-kB activation. Inflamm Res. 2007; 56: 479-486. (Pubitemid 351153460)
17. Akamatsu H, Horio T. The possible role of reactive oxygen species generated by neutrophils in mediating acne inflammation. Dermatology. 1998; 196: 82-85. (Pubitemid 28116048)
18. Akamatsu H, Horio T, Hattori K. Increased hydrogen peroxide generation by neutrophils from patients with acne inflammation. Int J Dermatol. 2003; 42: 366-369. (Pubitemid 36681718)
19. Burkhart CG, Burkhart CN, Lehmann PF. Acne: a review of immunologic and microbiologic factors. Postgrad Med J. 1999; 75: 328-331.
20. Jeremy AH, Holland DB, Roberts SG, et al. Inflammatory events are involved in acne lesion initiation. J Invest Dermatol. 2003; 121: 20-27.
21. Białecka A, Mak M, Biedroń R, et al. Different pro-inflammatory and immunogenic potentials of Propionibacterium acnes and Staphylococcus epidermidis: implication for chronic inflammatory acne. Arch Immunol Ther Exp. 2005; 53: 79-85. (Pubitemid 40364728)
22. Jappe U, Ingham E, Henwood J, et al. Propionibacterium acnes and inflammation in acne; P. acnes has T-cell mftogenic activity. Br J Dermatol. 2002; 146: 202-209. (Pubitemid 34264388)
23. Gans EH, Kligman AM. Comparative efficacy of clindamycin and benzoyl peroxide for in vivo suppression of P. acnes. J Dermatolog Treat. 2002; 13: 107-110.
24. Leyden J, Kaidbey K, Levy SF. The combination formulation of clindamycin 1% plus benzoyl peroxide 5% versus 3 different formulations of topical clindamycin alone in the reduction of Propionibacterium acnes. An in vivo comparative study. Am J Clin Dermatol. 2001; 2: 263-266. (Pubitemid 32738668)
25. Guay DR. Topical clindamycin in the management of acne vulgaris. Expert Opin Pharmacother. 2007; 8: 2625-2664. (Pubitemid 350031299)
26. Eady EA, Cove JH, Holland KT, et al. Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure. Br J Dermatol. 1989; 121: 51-57.
27. Leyden JJ. Antibiotic resistance in the topical treatment of acne vulgaris. Cutis. 2004; 73: 6-10.
28. Dreno B. Topical antibacterial therapy for acne vulgaris. Drugs. 2004; 64: 2389-2397. (Pubitemid 39472628)
29. Tan HH. Topical antibacterial treatments for acne vulgaris: comparative review and guide to selection. Am J Clin Dermatol. 2004; 5: 79-84.
30. Marcinkiewicz J, Wojas-Pelc A, Walczewska M, et al. Topical taurine bromamine, a new candidate in the treatment of moderate inflammatory acne vulgaris: a pilot study. Eur J Dermatol. 2008; 18: 433-439. (Pubitemid 352031854)
31. Hanselmann C, Mauch C, Werner S. Haem oxygenase-1: a novel player in cutaneous wound repair and psoriasis? Biochem J. 2001; 353: 459-466.